Literature DB >> 30604335

Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature.

Sergio Racchiusa1, Enricomaria Mormina2,3, Antonietta Ax2, Olimpia Musumeci3, Marcello Longo2, Francesca Granata2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is an encephalopathy characterized by a rapid onset of symptoms including headache, seizures, confusion, blurred vision, and nausea associated with a typical magnetic resonance imaging appearance of reversible subcortical vasogenic edema prominent and not exclusive of parieto-occipital lobes. Vasogenic edema is caused by a blood-brain barrier leak induced by endothelial damage or a severe arterial hypertension exceeding the limits of cerebral blood flow autoregulation. Although the exact pathophysiological mechanism is still unclear, frequent conditions that may induce PRES include severe hypertension, eclampsia/pre-eclampsia, acute kidney diseases and failure, immunosuppressive therapy, solid organ, or bone marrow transplantation. Conversely to other conditions, which may induce PRES, the link between severe infection or sepsis and PRES, often associated with gram-positive bacteria, is still poorly understood and less well known. Clinicians from multiple disciplines, such as neurologists and internists, may encounter during their profession patients with severe infection or sepsis and should consider the possible association between PRES and these conditions. We systematically reviewed the literature about this association in order to provide a helpful clinical insight of such complex pathophysiological mechanism, highlighting the importance of recognizing PRES in such a complex clinical scenario.

Entities:  

Keywords:  Infection; PRES; Posterior reversible encephalopathy syndrome; Sepsis

Mesh:

Year:  2019        PMID: 30604335     DOI: 10.1007/s10072-018-3651-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  Etiology and clinical characteristics of pediatric non-neoplastic posterior reversible encephalopathy: systematic review.

Authors:  Mariana Jordão; Pedro Raimundo; Ruben Jacinto; Daniel Garrido; João Martins; Rui Estevens; Jerina Nogueira; Emanuel Fernandes; Ana Macedo; Hipólito Nzwalo
Journal:  Porto Biomed J       Date:  2022-06-17

2.  Clinical characteristics and outcomes of patients admitted to hospitals for posterior reversible encephalopathy syndrome: a retrospective cohort study.

Authors:  Abbas Alshami; Asseel Al-Bayati; Steven Douedi; Mohammad A Hossain; Swapnil Patel; Arif Asif
Journal:  BMC Neurol       Date:  2021-03-09       Impact factor: 2.474

3.  Posterior Reversible Encephalopathy Syndrome in a Patient With Microscopic Polyangiitis: A Case Report and Literature Review.

Authors:  Jing Xu; Ying Ding; Zhen Qu; Feng Yu
Journal:  Front Med (Lausanne)       Date:  2021-12-24

4.  Posterior Reversible Encephalopathy Syndrome: A Rare Complication in COVID-19.

Authors:  Anwar J Alnass; Rahaf A Alamer; Hend H Alamri; Azzah A Alharthi; Majd A Assad; Mohammed K Al Sedran; Dunya A Bu-Izran; Bayan F Mirza; Amwaj A Almalki; Malak Alshammari
Journal:  Cureus       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.